- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/035 - Virus de l'herpès simplex I ou II
Détention brevets de la classe C07K 14/035
Brevets de cette classe: 139
Historique des publications depuis 10 ans
|
14
|
11
|
13
|
11
|
10
|
12
|
4
|
5
|
8
|
5
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Alma Mater Studiorum - Universita di Bologna | 437 |
9 |
| The Trustees of the University of Pennsylvania | 4415 |
8 |
| The Brigham and Women's Hospital, Inc. | 2286 |
6 |
| Glaxosmithkline Biologicals S.A. | 1602 |
4 |
| Albert Einstein College of Medicine, Inc. | 596 |
4 |
| Squarex, LLC | 8 |
4 |
| KM Biologics Co., Ltd | 93 |
4 |
| Gen-Probe Incorporated | 1039 |
3 |
| Genocea Biosciences, Inc. | 26 |
3 |
| University of Tennessee Research Foundation | 763 |
3 |
| University of Washington | 2448 |
3 |
| The Wistar Institute of Anatomy and Biology | 484 |
3 |
| Nanjing Legend Biotech Co., Ltd. | 186 |
3 |
| Virogin Biotech Canada Ltd. | 54 |
3 |
| Imunotera Soluções Terapêuticas Ltda. | 5 |
3 |
| Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | 824 |
2 |
| The University of Tokyo | 4361 |
2 |
| Novo Nordisk A/S | 2279 |
2 |
| Excision BioTherapeutics, Inc. | 21 |
2 |
| Virion Therapeutics, LLC | 15 |
2 |
| Autres propriétaires | 66 |